We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETRN
1601
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
– –
-158,605
Closed -$3.13M
KRTX
1602
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-50,325
Closed -$1.01M
EXPR
1603
DELISTED
Express, Inc.
EXPR
– –
-626
Closed -$34K
SIEN
1604
DELISTED
Sientra, Inc.
SIEN
– –
-33,776
Closed -$2.08M
ORTX
1605
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-13,057
Closed -$1.83M
MRTX
1606
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-19,708
Closed -$2.03M
CHS
1607
DELISTED
Chicos FAS, Inc.
CHS
– –
-142,550
Closed -$480K
VAPO
1608
DELISTED
Vapotherm, Inc. Common Stock
VAPO
– –
-2,708
Closed -$498K
SGEN
1609
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-84,316
Closed -$5.84M
CEQP
1610
DELISTED
Crestwood Equity Partners LP
CEQP
– –
-6,575
Closed -$235K
NATI
1611
DELISTED
National Instruments Corp
NATI
– –
-28,967
Closed -$1.22M
VRAY
1612
DELISTED
ViewRay, Inc.
VRAY
– –
-577,102
Closed -$5.08M
LSI
1613
DELISTED
Life Storage, Inc.
LSI
– –
-3,173
Closed -$201K
MGI
1614
DELISTED
MoneyGram International, Inc. New
MGI
– –
-20,751
Closed -$51K
VNTR
1615
DELISTED
Venator Materials PLC
VNTR
– –
-32,113
Closed -$170K
BBBY
1616
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-239,892
Closed -$2.79M
IAA
1617
DELISTED
IAA, Inc. Common Stock
IAA
– –
-84,046
Closed -$3.26M
ALBO
1618
DELISTED
Albireo Pharma Inc
ALBO
– –
-39,888
Closed -$1.29M
UMPQ
1619
DELISTED
Umpqua Holdings Corp
UMPQ
– –
-225,836
Closed -$3.75M
LCI
1620
DELISTED
Lannett Company, Inc.
LCI
– –
-7,975
Closed -$194K
ASAP
1621
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
– –
-1,039
Closed -$131K
TTM
1622
DELISTED
Tata Motors Limited
TTM
– –
-71,833
Closed -$839K
CLR
1623
DELISTED
CONTINENTAL RESOURCES INC.
CLR
– –
-260,941
Closed -$11M
ZEN
1624
DELISTED
ZENDESK INC
ZEN
– –
-123,131
Closed -$11M
TEN
1625
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
– –
-13,476
Closed -$149K
63 64
65
66 67

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.